Michael Merger

Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities

Phillip D. Smith, Lesley E. Smythies, Meg Mosteller‐Barnum et al. · The Journal of Immunology · 2001 · 323 citations · Full text

Life Sciences, Immunology, Microbiology +17

Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer

Jonathan A. Ledermann, Allan Hackshaw, Stan Kaye et al. · Journal of Clinical Oncology · 2011 · 214 citations

Medicine, Oncology, Pharmacology +16

Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine

Alexander Gebauer, Michael Merger, H. Kilbinger · Naunyn-Schmiedeberg s Archives of Pharmacology · 1993 · 130 citations

Medicine, Neuroscience, Pharmacology +13

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine

Michael Merger, Joanne L. Viney, Rajka Borojevic et al. · Gut · 2002 · 102 citations · Full text

Medicine, Immunology, Pathology +17

Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine

Phillip D. Smith, Edward N. Janoff, Meg Mosteller-Barnum et al. · Journal of Immunological Methods · 1997 · 97 citations

Life Sciences, Cell Biology, Immunology +14